CD8A and neoplasm: Recent data from melanoma patients revealed that the administration of stools from responders to immune checkpoint inhibitors (ICI) to non-responders can revert the primary resistance to these agents and lead to increased tumor infiltration by CD8 T cells [131], as previously suggested in pre-clinical studies [127].